Kilitch Drugs (India) Ltd.

BSE: 524500 | NSE: KILITCH |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE729D01010 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Kilitch Drugs Kilitch Drugs (India) Ltd. | BSE 379.20 -11.35 (-2.91%) | NSE 378.10 -10.25 (-2.64%) | Trade | Add

BSE Live

Nov 03, 16:01

379.20 -11.35 (-2.91%)

Volume

AVERAGE VOLUME

5-Day

9,876

10-Day

5,985

30-Day

3,204

5,656

Prev. Close

390.55
Open Price

390.55

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 03, 15:51

378.10 -10.25 (-2.64%)

Volume

AVERAGE VOLUME

5-Day

148,429

10-Day

87,477

30-Day

35,156

43,963

Prev. Close

388.35
Open Price

390.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
378.10 (128)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Kilitch Drugs (India) (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	197.24	153.61	138.86	112.96	68.13
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	197.24	153.61	138.86	112.96	68.13
Total Operating Revenues	198.32	154.37	139.60	114.23	68.52
Other Income	11.16	4.48	2.92	2.91	2.67
Total Revenue	209.48	158.85	142.52	117.14	71.19
EXPENSES
Cost Of Materials Consumed	105.75	79.08	74.53	65.48	36.22
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.00	0.00
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-1.17	-0.12	0.23	-0.05	1.09
Employee Benefit Expenses	11.32	10.01	11.73	6.18	5.24
Finance Costs	5.04	5.93	4.92	1.20	0.75
Depreciation And Amortisation Expenses	3.11	3.35	3.55	2.47	1.99
Other Expenses	50.95	41.24	35.54	32.25	20.78
Total Expenses	175.00	139.50	130.50	107.53	66.07
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	34.47	19.35	12.01	9.61	5.12
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	34.47	19.35	12.01	9.61	5.12
Tax Expenses-Continued Operations
Current Tax	9.85	6.37	4.20	3.63	1.67
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.32	-0.59	-0.47	-0.23	-0.31
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	9.53	5.78	3.73	3.40	1.35
Profit/Loss After Tax And Before ExtraOrdinary Items	24.94	13.58	8.28	6.21	3.77
Profit/Loss From Continuing Operations	24.94	13.58	8.28	6.21	3.77
Profit/Loss For The Period	24.94	13.58	8.28	6.21	3.77
Minority Interest	1.76	1.03	2.17	1.15	-0.10
Consolidated Profit/Loss After MI And Associates	26.70	14.60	10.45	7.37	3.67
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	17.00	9.00	7.00	5.00	2.00
Diluted EPS (Rs.)	17.00	9.00	7.00	5.00	2.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00